Mac-2BP Polyclonal Antibody |
|||
| ES8657-50ul | ELK Biotech | 50ul | EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Mac-2BP from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
Mac-2BP Polyclonal Antibody |
|||
| ABP59179-003ml | Abbkine | 0.03ml | EUR 158 |
|
Description: A polyclonal antibody for detection of Mac-2BP from Human, Mouse. This Mac-2BP antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Mac-2BP protein at amino acid sequence of 100-160 |
|||
Mac-2BP Polyclonal Antibody |
|||
| ABP59179-01ml | Abbkine | 0.1ml | EUR 289 |
|
Description: A polyclonal antibody for detection of Mac-2BP from Human, Mouse. This Mac-2BP antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Mac-2BP protein at amino acid sequence of 100-160 |
|||
Mac-2BP Polyclonal Antibody |
|||
| ABP59179-02ml | Abbkine | 0.2ml | EUR 414 |
|
Description: A polyclonal antibody for detection of Mac-2BP from Human, Mouse. This Mac-2BP antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Mac-2BP protein at amino acid sequence of 100-160 |
|||
Anti-Mac-2BP antibody |
|||
| STJ98720 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Mac-2BP. |
|||
Mac-2BP Polyclonal Antibody |
|||
| 46771-100ul | SAB | 100ul | EUR 252 |
Mac-2BP Polyclonal Antibody |
|||
| 46771-50ul | SAB | 50ul | EUR 187 |
Mac-2BP Polyclonal Conjugated Antibody |
|||
| C46771 | SAB | 100ul | EUR 397 |
Monoclonal MAC-2-BP / LGALS3BP Antibody (clone 2B1), Clone: 2B1 |
|||
| AMM02212G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A Monoclonal antibody against Human MAC-2-BP / LGALS3BP (clone 2B1). The antibodies are raised in Mouse and are from clone 2B1. This antibody is applicable in WB and IHC-P, Flo |
|||
Anti-ErbB 2/ERBB2 Antibody |
|||
| A00010-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Bcl-2/BCL2 Antibody |
|||
| A00040-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Angiopoietin-2/ANGPT2 Antibody |
|||
| A00370-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Fascin 2/FSCN2 Antibody |
|||
| A07840-2 | BosterBio | 100ug/vial | EUR 294 |
Anti-EIF4A1/2/3 Antibody |
|||
| A03922-2 | BosterBio | 100ug/vial | EUR 334 |
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCA0271-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),APC conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCAP0271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCAP0271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC810271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC810271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC880271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC880271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCB0271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCB0271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC550271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC550271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC430271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC430271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC470271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC470271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC940271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC940271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCP0271-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC040271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC040271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC050271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC050271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCR0271-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),RPE conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNUB0271-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271), Concentration: 0.2mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNUB0271-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271), Concentration: 0.2mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC680271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC680271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC700271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC700271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC800271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC800271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC400271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC400271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC610271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNC610271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCH0271-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNCH0271-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD11b / MAC-1 (Microglial Marker) (ITGAM/271) Antibody |
|||
| BNUM0271-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against CD11b / MAC-1 (Microglial Marker) (ITGAM/271), 1mg/mL |
|||
Anti-Bcl-2 Rabbit Monoclonal Antibody |
|||
| M00040-2 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal Bcl-2 Antibody. Validated in IF, WB and tested in Human, Mouse. |
|||
Anti-HIF-2-alpha/EPAS1 Antibody |
|||
| PA1129-2 | BosterBio | 100ug/vial | EUR 294 |
Anti-COX2/Cyclooxygenase 2/PTGS2 Antibody |
|||
| A00084-2 | BosterBio | 100ug/vial | EUR 294 |
Anti-p56Dok-2 (Ab-299) Antibody |
|||
| A07956-2 | BosterBio | 100ul | EUR 397 |
|
Description: Rabbit Polyclonal p56Dok-2 (Ab-299) Antibody. Validated in IF, IHC, WB and tested in Human. |
|||
Anti-beta 2 Microglobulin/B2m Antibody |
|||
| A00456-2 | BosterBio | 100ug/vial | EUR 294 |
Anti-VEGF Receptor 2/KDR Antibody |
|||
| A00901-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Adiponectin Receptor 2 (mouse) Antibody |
|||
| A02218-2 | BosterBio | 200ug | EUR 498 |
|
Description: Goat Polyclonal Adiponectin Receptor 2 (mouse) Antibody. Validated in IF, IHC and tested in Mouse. |
|||
Anti-Anterior Gradient 2/AGR2 Antibody |
|||
| A02922-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-Beta 2 Microglobulin Antibody (monoclonal, 2H10) |
|||
| M00456-2 | BosterBio | 100ug/vial | EUR 334 |
Anti-COX-2 Rabbit Monoclonal Antibody, Clone#RM348 |
|||
| M00084-2 | BosterBio | 100uL | EUR 397 |
|
Description: Anti-COX-2 Rabbit Monoclonal Antibody, Clone#RM348 tested in WB, IHC, reactive to Human |
|||
Anti-Rsk 2/MAPKAP Kinase 1b/RPS6KA3 Antibody |
|||
| A02215-2 | BosterBio | 100ug/vial | EUR 334 |
Human membrane attack complex(MAC)ELISA Kit |
|||
| GA-E0376HM-48T | GenAsia Biotech | 48T | EUR 289 |
Human membrane attack complex(MAC)ELISA Kit |
|||
| GA-E0376HM-96T | GenAsia Biotech | 96T | EUR 466 |
Human membrane attack complex,MAC ELISA Kit |
|||
| 201-12-0360 | SunredBio | 96 tests | EUR 440 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Membrane Attack Complex (MAC) ELISA Kit |
|||
| abx350654-96tests | Abbexa | 96 tests | EUR 668 |
Rabbit membrane attack complex(MAC)ELISA Kit |
|||
| QY-E30025 | Qayee Biotechnology | 96T | EUR 374 |
Human membrane attack complex(MAC)ELISA Kit |
|||
| QY-E02156 | Qayee Biotechnology | 96T | EUR 361 |
Human membrane attack complex,MAC ELISA Kit |
|||
| CN-04250H1 | ChemNorm | 96T | EUR 442 |
Human membrane attack complex,MAC ELISA Kit |
|||
| CN-04250H2 | ChemNorm | 48T | EUR 293 |
2-Propyl-β-D-glucuronide, 2 mg |
|||
| 0904-2 | AthenaES | 2 mg | EUR 162 |
IL-2 Interleukin-2 Human Recombinant Protein, His Tag |
|||
| PROTP60568-2 | BosterBio | Regular: 10ug | EUR 317 |
|
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_ |
|||
BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer |
|||
| PROTP12643-2 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques. |
|||
PG LIVER 2 EA* |
|||
| 59423-2 | Pel-Freez | 2 EA | EUR 192.24 |
Individual Reaction Mix 2 |
|||
| G065-2 | ABM | 200 reactions | EUR 167 |
ELISA kit for Human MAC (Membrane Attack Complex) |
|||
| E-EL-H5418 | Elabscience Biotech | 1 plate of 96 wells | EUR 534 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human MAC (Membrane Attack Complex) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Human Membrane attack complex (MAC) |
|||
| KTE62641-48T | Abbkine | 48T | EUR 354 |
|
Description: Quantitative sandwich ELISA for measuring Human Membrane attack complex (MAC) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Membrane attack complex (MAC) |
|||
| KTE62641-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2252 |
|
Description: Quantitative sandwich ELISA for measuring Human Membrane attack complex (MAC) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Membrane attack complex (MAC) |
|||
| KTE62641-96T | Abbkine | 96T | EUR 572 |
|
Description: Quantitative sandwich ELISA for measuring Human Membrane attack complex (MAC) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Recombinant Human Relaxin-2 Protein |
|||
| PROTP04090-2 | BosterBio | 25ug | EUR 317 |
|
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain. |
|||
Recombinant Murine IL-2 Protein |
|||
| PROTP04351-2 | BosterBio | 20ug | EUR 317 |
|
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues. |
|||
Recombinant Human PAI-2 Protein |
|||
| PROTP05120-2 | BosterBio | 10ug | EUR 317 |
|
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein. |
|||
Recombinant Human MMP-2 Protein |
|||
| PROTP08253-2 | BosterBio | 10ug | EUR 317 |
|
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids). |
|||
Recombinant Human BD-2 Protein |
|||
| PROTO15263-2 | BosterBio | 20ug | EUR 317 |
|
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues. |
|||
Bovine KIDNEY WHOLE 2 EA* |
|||
| 57120-2 | Pel-Freez | 2 EA | EUR 174.84 |
Mouse FGF-2 Recombinant Protein |
|||
| R00121-2 | BosterBio | 5ug/vial | EUR 259 |
|
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast. |
|||
Chicken IL-2 Recombinant Protein |
|||
| R00387-2 | BosterBio | 5ug/vial | EUR 259 |
|
Description: Interleukin-2 (IL-2) is a cytokine produced by T-helper cells in response to antigenic or mitogenic stimulation. It is required for T-cell proliferation and other activities crucial to the regulation of the immune response. Chicken IL-2 Recombinant Protein is purified interleukin-2 produced in yeast. |
|||
Recombinant Human TFF-2 Protein |
|||
| PROTQ03403-2 | BosterBio | 20ug | EUR 317 |
|
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 107 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds. |
|||
pLenti-CARM1 shRNA-2 Plasmid |
|||
| PVTBAV03691-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-CTLA4 shRNA-2 Plasmid |
|||
| PVTBAV05689-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-FOXM1 shRNA-2 Plasmid |
|||
| PVTBAV08732-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-JUN shRNA-2 Plasmid |
|||
| PVTBAV11741-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-LHX6 shRNA-2 Plasmid |
|||
| PVTBAV12881-2 | Lifescience Market | 2 ug | EUR 356 |
pLenti-MAGEA3 shRNA-2 Plasmid |
|||
| PVTBAV13661-2 | Lifescience Market | 2 ug | EUR 356 |